Cite
Patients with IPSS-R Intermediate Risk can be Separated Into Three Risk Groups
MLA
U. Germing, et al. “Patients with IPSS-R Intermediate Risk Can Be Separated Into Three Risk Groups.” Leukemia Research, vol. 55, Apr. 2017, p. S147. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a1902993adb4c86161498a57109f3530&authtype=sso&custid=ns315887.
APA
U. Germing, Kathrin Nachtkamp, Stephan Baldus, Barbara Hildebrandt, Martina Rudelius, Andrea Kündgen, T. Reykowski, Rainer Haas, Judith Neukirchen, Corinna Strupp, & Tobias Schroeder. (2017). Patients with IPSS-R Intermediate Risk can be Separated Into Three Risk Groups. Leukemia Research, 55, S147.
Chicago
U. Germing, Kathrin Nachtkamp, Stephan Baldus, Barbara Hildebrandt, Martina Rudelius, Andrea Kündgen, T. Reykowski, et al. 2017. “Patients with IPSS-R Intermediate Risk Can Be Separated Into Three Risk Groups.” Leukemia Research 55 (April): S147. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a1902993adb4c86161498a57109f3530&authtype=sso&custid=ns315887.